We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
-7.89%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
-$29.7M
Cap. Flow
+$110M
Cap. Flow %
10.28%
Top 10 Hldgs %
55.73%
Holding
349
New
26
Increased
163
Reduced
134
Closed
15

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$35.5M
2
GRAB icon
Grab
GRAB
+$33.3M
3
QCOM icon
Qualcomm
QCOM
+$25.7M
4
AMD icon
Advanced Micro Devices
AMD
+$21.8M
5
SE icon
Sea Limited
SE
+$18.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.29%
2 Technology 26.19%
3 Communication Services 11.91%
4 Healthcare 11.24%
5 Real Estate 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYEL icon
326
Lyell Immunopharma
LYEL
$317M
$104K 0.01%
+710
New +$96.1K
MRSN
327
DELISTED
Mersana Therapeutics
MRSN
$99K 0.01%
+588
New +$95.6K
ADMA icon
328
ADMA Biologics
ADMA
$2.03B
$97K 0.01%
+39,858
New +$95.6K
MCRB icon
329
Seres Therapeutics
MCRB
$49.5M
$90K 0.01%
+704
New +$72.1K
GERN icon
330
Geron
GERN
$924M
$89K 0.01%
37,938
-1,054
-3% -$2.36K
PNT
331
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$79K 0.01%
+10,212
New +$86.7K
MDXG icon
332
MiMedx Group
MDXG
$645M
$32K ﹤0.01%
11,207
-787
-7% -$2.8K
TCRT icon
333
Alaunos Therapeutics
TCRT
$4.96M
$26K ﹤0.01%
+101
New +$29.3K
ADAG
334
Adagene
ADAG
$239M
$13K ﹤0.01%
10,310
-9,000
-47% -$14.2K
GS icon
335
Goldman Sachs
GS
$311B
-682
Closed -$203K
ITOS
336
DELISTED
iTeos Therapeutics
ITOS
-11,236
Closed -$231K
LMT icon
337
Lockheed Martin
LMT
$117B
-471
Closed -$203K
MTCH icon
338
Match Group
MTCH
$9.11B
-3,294
Closed -$230K
NUGT icon
339
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$769M
-19,048
Closed -$654K
ORGO icon
340
Organogenesis Holdings
ORGO
$338M
-25,808
Closed -$126K
PRAX icon
341
Praxis Precision Medicines
PRAX
$8.49B
-1,738
Closed -$64K
RIGL icon
342
Rigel Pharmaceuticals
RIGL
$734M
-12,482
Closed -$141K
UGL icon
343
ProShares Ultra Gold
UGL
$636M
-71,612
Closed -$1.01M
ZM icon
344
Zoom
ZM
$26.7B
-2,403
Closed -$259K
MORF
345
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-9,266
Closed -$201K
TPTX
346
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-4,268
Closed -$321K
RDUS
347
DELISTED
Radius Health, Inc.
RDUS
-13,662
Closed -$142K
DIDI
348
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
-2,203,522
Closed -$6.5M
BHVN
349
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-3,039
Closed -$443K

Similar funds

E Fund Management's Q3 2022 Portfolio in Review

As of Q3 2022, E Fund Management held 349 positions worth $1.07B, down 2.7% from $1.1B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

E Fund Management deployed $110M of net new capital in Q3 2022, opening 26 new positions and adding to 163 existing holdings. Its largest new stake was TSMC: 430,000 shares worth $29.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, down from 36% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Mercado Libre, an estimated $26.6M trimmed.

  • E Fund Management's largest Q3 2022 buy was TSMC: 430,000 shares worth $29.5M.
  • E Fund Management added most to Grab in Q3 2022, an estimated $33.3M increase.
  • E Fund Management's biggest Q3 2022 reduction was Mercado Libre, cutting an estimated $26.6M.
  • E Fund Management fully exited DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share in Q3 2022, selling an estimated $6.5M.
  • E Fund Management's ten largest holdings make up 56% of its $1.07B portfolio in Q3 2022.
  • E Fund Management opened 26 new positions and closed 15 in Q3 2022.
  • E Fund Management's portfolio value fell 2.7% quarter-over-quarter to $1.07B.

Based on E Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.